3Matsui M,Nishigori C,Toyokuni S,et al.The role of oxidative DNA damage in human arsenic carcinogenesis:detection of 8-hydroxy-2'-deoxyguanosinein arsenic-related Bowen's disease[J].J Invest Dermatol,1999,113(1):26-31.
4Zheng W.Toxicology of choriod plexus:special reference to metal-inducedneurotoxicities[J].Microse Res Tech,2001,52(1):89-103.
7Takahashi M,Barrett JC,Tsutsui T,et al.Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independentand cause tumors in newborn hamsters[J].Int J Cancer,2002,99(5):629-634.
9Chanda S,Dasgupta UB,Guhamazumder D,et al.DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy[J].Toxicol Sci,2006,89(2):431-437.
10Marc J.Mass,Liangjun Wang.Arsenic alters cytosine methylation patterns of the promoter of tumor suppressor gene p53 in human lung cells:a model for a mecha-nism of carcinogenesis[J].Mutat Res,1997,386(3):263-277.
6Kantarjian HM, O'Brein S, Cortes J, et al. Results of decitabine (5-aza-2' deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia [J]. Cancer, 2003,98(3): 522-528.
7Reddy J, Shivapurkar N, methylation of genes that Takahashi T, et al. Differential regulate cytokine signaling in lymphoid and hematopoietic tumors [J]. Oncogene, 2005,24 (4) :732-736.
8Wu C, Sun M, Liu L, et al. The function of the protein tyrosine phosphatase SHP-1 in cancer [J]. Gene,2003,306 (3):1-12.
9Oka T, Yoshino T, Hayashi K, et al. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types lymphomas/leukemia [J]. Am J Pathol, 2001,159(4) :495- 505.
10Kozlowski M, Larose L, Lee F, et al. SHP-1 binds and negatively modulates the c-kit receptor by interaction with tyrosine 569 in the c-kit juxtamembrane domain [J]. Mol Cell Biol, 1998,18(4) :2089-2099.